Pharmacy Website

Opportunities for Clinical Faculty

Click here for information on publishing journal articles and submitting posters to national professional organizations.  Includes author guidelines, deadlines and opportunities to become a reviewer.

 

GRANT OPPORTUNITIES FOR CLINICAL FACULTY

AACP Research, Grants and Scholarships
ACCP Foundation Opportunities
ASHP Foundation Opportunities
APhA Foundation Opportunities
ASPET Research Opportunities

AFPE Foundation Opportunities
Community Pharmacy Foundation Opportunities
NACDS Foundation Opportunities
PhRMA Foundation Opportunities


Decision, Risk and Management Sciences  (DRMS)

The Decision, Risk and Management Sciences program supports scientific research directed at increasing the understanding and effectiveness of decision making by individuals, groups, organizations, and society. Disciplinary and interdisciplinary research, doctoral dissertation research, and workshops are funded in the areas of judgment and decision making; decision analysis and decision aids; risk analysis, perception, and communication; societal and public policy decision making; management science and organizational design. The program also supports small grants that are time-critical (Rapid Response Research - RAPID)and small grants that are high-risk and of a potentially transformative nature (EArly-Concept Grants for Exploratory Research - EAGER).

Announcement #:  PD-1321
Posted:  February 17, 2012
Proposal due date:  Annual Jan 18 and Aug 18
Funding level: Not specified, see announcement

 

RWJF Changes in Health Care Financing and Organization (HCFO)

Changes in Health Care Financing and Organization (HCFO) supports research, policy analysis and evaluation projects that provide policy leaders timely information on health care policy, financing and organization issues. Supported projects include:
    - examining significant issues and interventions related to health care financing and organization and their effects on health care costs, quality and access; and
    - exploring or testing major new ways to finance and organize health care that have the potential to improve access to more affordable and higher quality health services.

Funding Level:    Small grants for projects requiring $100,000 or less and projected to take up to 12 months or less.
                         Large grants for projects requiring more than $100,000 and/or projected to take longer than 12 months.
Due Date: Open, rolling

AETNA FOUNDATION

We focus our grant-making on issues that improve health and the health care system in the following three areas: 1. Obesity: Addressing the rising rate of obesity among U.S. adults and children. 2. Racial and Ethnic Health Care Equity: Promoting equity in health and health care for common chronic conditions and infant mortality. 3. Integrated Health Care: Advancing high-quality health care by improving care coordination and communications among health care professionals; creating informed and involved patients; and promoting cost-effective, affordable care
Funding Level: $25,000 to $50,000
Letter of Intent Due:  Letters of Inquiry are accepted on a rolling basis.
Due Date:   May 15, August 15, November 15

BLUE CROSS FOUNDATION

In addition to funding projects initiated by nonprofit organizations and submitted for consideration through the Foundation’s online grant application system, the Foundation develops its own signature initiatives. Examples include Healthy U, a childhood obesity program serving more than 20,000 children throughout New Jersey and the Health Center Initiative that has supported 20 Federally Qualified Health Centers and independent health centers across the state. To learn more about these programs, click on the program name on the navigation bar to the left.
Due dates vary – check website.

PFIZER FOUNDATION

Pfizer seeks to provide grant support for the continuing professional development of healthcare providers in areas aligned with the core competencies established by the Accreditation Council for Graduate Medical Education (ACGME) and American Board of Medical Specialties (ABMS). The six competencies are in the areas of:
•    Patient Care
•    Medical Knowledge
•    Interpersonal and Communication Skills
•    Professionalism
•    Systems-based Practice
•    Practice-based Learning and Improvement
Due dates vary – check website.

 

  Government Opportunities
NIH

click here for NIH "medication" opportunities
click here for NIH "clinical" opportunities

 
Research on the Health of LGBTI Populations [R01]

The
National Institutes of Health (NIH) is committed to supporting research
that will increase scientific understanding of the health status of
various population groups and improve the effectiveness of health
interventions and services for individuals within those groups.  High
priority is placed on research on populations that appear to have
distinctive health risk profiles but have received insufficient
attention from investigators.  This Funding Opportunity Announcement
(FOA) highlights a particular community:  lesbian, gay, bisexual,
transgender, intersex, and related populations (designated here as LGBTI
populations).  Basic, social, behavioral, clinical, and services
research relevant to the missions of the sponsoring Institutes and
Centers may be proposed. 

Announcement #:  PAR-12-111
Posted: February 23, 2012
Funding Level: Not specified up to 5 years
Letter of Intent Due: NA
Due Date: June 5, october 5, February 5; exp. May 8, 2015

Research on the Health of LGBTI Populations (R21)   

The
National Institutes of Health (NIH) is committed to supporting research
that will increase scientific understanding of the health status of
various population groups and improve the effectiveness of health
interventions and services for individuals within those groups.  High
priority is placed on research on populations that appear to have
distinctive health risk profiles but have received insufficient
attention from investigators.  This Funding Opportunity Announcement
(FOA) highlights a particular community:  lesbian, gay, bisexual,
transgender, intersex, and related populations (designated here as LGBTI
populations).  Basic, social, behavioral, clinical, and services
research relevant to the missions of the sponsoring Institutes and
Centers may be proposed. 

Announcement #:  PAR-12-113
Posted: February 23, 2012
Funding Level: $275,000 per year for 2 years
Letter of Intent Due: NA
Due Date: June 16, October 16, February 16; exp. May 8, 2015


Research on the Health of LGBTI Populations [R03]

The
National Institutes of Health (NIH) is committed to supporting research
that will increase scientific understanding of the health status of
various population groups and improve the effectiveness of health
interventions and services for individuals within those groups.  High
priority is placed on research on populations that appear to have
distinctive health risk profiles but have received insufficient
attention from investigators.  This Funding Opportunity Announcement
(FOA) highlights a particular community:  lesbian, gay, bisexual,
transgender, intersex, and related populations (designated here as LGBTI
populations).  Basic, social, behavioral, clinical, and services
research relevant to the missions of the sponsoring Institutes and
Centers may be proposed. 

Announcement #:  PAR-12-112
Posted: February 23, 2012
Funding Level: $50,000 per year for 2 years
Letter of Intent Due: NA
Due Date: June 16, October 16, February 16; exp. May 8, 2015

   
Infrastructure Development Program in Patient-Centered Outcomes Research (PCOR) (R24)

Purpose.
This FOA solicits Resource-Related Research Projects (R24) grant
applications from organizations that propose to improve health outcomes
by developing and disseminating evidence-based information to patients,
clinicians, policy makers, and health care administrators, responding to
their expressed needs about which clinical and health system design
interventions are most effective for which patients under specific
circumstances. Mechanism of Support. This FOA will use the AHRQ
Resource-Related Research Projects (R24) grant mechanism. Funds
Available and Anticipated Number of Awards. Because the nature and scope
of the proposed research will vary from application to application, it
is anticipated that the size and duration of each award will also vary.
The total amount awarded and the number of awards will depend upon the
numbers, quality, duration, and costs of the applications received.
Awards issued under this FOA are contingent upon the availability of
funds and the submission of a sufficient number of meritorious
applications.

Announcement #:PA-12-114
Posted: February 23, 2012
Funding Level: $250,000 per year up to 3 or 5 years
Letter of Intent Due:  NA
Due Date:  June 12, 2012, December 19, 2012, December 19, 2013, December 19, 2014

 

Data Concepts and Terminology Standards for Clinical Research and Drug Development (R24)

The FDA Center for Drug Evaluation and Research is encouraging grant applications for programs to expedite development of data concepts and terminology to support human drug development and evaluation.  The primary objective is to support the development of non-proprietary, consensus-based, national data standards for use in clinical studies of human drugs and biologics.  Projects may focus on solutions to general data standards development and implementation challenges or on specific clinical concepts or domains where standardization is needed.
Announcement #: PAR-11-209
Posted:  April 28, 2011
Funding Level: $150,000 up to 2 years
Letter of Intent Due:  NA
Due Date:  November 15, 2012, June 1,2013; November 15, 2013

 Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01)

This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) encourages Research Project Grant (R01) applications to test the utility and implementation of technological tools, including mobile devices, to promote engagement in Human Immunodeficiency Virus (HIV) care among substance abusing populations with HIV. Research projects may focus on (a) the use of technology to directly improve patient-level outcomes (i.e., adherence); (b) the capacity of HIV treatment providers and related service delivery organizations to adopt and integrate such technologies to promote HIV treatment outcomes; or (c) the use of technology to improve the organization and delivery of HIV treatment and services.

Announcement #: PA-12-117
Posted:  March 23, 2012
Funding Level: Not specified up to 5 years
Letter of Intent Due:  NA
Due Date:  February 5, June 5, October 5; exp. Jan. 8, 2015

Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence and For Substance Abusing Populations with HIV (R34)

This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) encourages Clinical Trial Planning Grant (R34) applications to develop, pilot test and determine the feasibility of technology tools, including mobile devices, to promote engagement in Human Immunodeficiency Virus (HIV) care among substance abusing populations with HIV. Research projects may focus on: (a) the use of technology to directly improve patient-level outcomes (i.e., adherence); (b) the capacity of HIV treatment providers and related service delivery organizations to adopt and integrate such technologies to promote HIV treatment outcomes; or (c) the use of technology to improve the organization and delivery of HIV treatment and services.

Announcement #: PA-12-118
Posted:  March 23, 2012
Funding Level:  $450,000 over 3 years
Letter of Intent Due: NA 
Due Date:  February 16, June 16, October 16; exp. Jan. 8, 2015

NIH:  NIAMS Clinical Trial Implementation Cooperative Agreement (U01)

This Funding Opportunity Announcement (FOA) issued by the NIAMS invites cooperative agreement (U01) applications for implementation of investigator -initiated interventional clinical trials (all phases). This U01 FOA, which allows for the electronic submission of applications for single-site projects, compliments the previously released UM1 FOA, which permits submission of paper applications for multi-site projects. Applications for clinical trials submitted to the NIAMS are normally expected to go through a two-part process, which begins with a U34 planning phase (Part 1) followed by an application for the U01. Investigators who have completed all necessary pre-trial planning and preparation through other means may also apply for a NIAMS U01. Consultation with NIAMS staff is strongly encouraged prior to the submission of the clinical trial implementation U01 application. The NIAMS expects such trials to be hypothesis driven, milestone-defined, related to the research mission of the NIAMS, and considered high-priority by the institute.

Announcement #: PAR-11-219
Posted:  May 27, 2011
Funding Level:  not specified, up to five years
Letter of Intent Due:  August 15, 2011, December 15, 2011, April 15, 2012, August 15, 2012, December 15, 2012, April 15, 2013, August 15, 2013, December 15, 2013
Due Date:   November 1, 2012, March 1, 2013, July 1, 2013, November 1, 2013, March 3, 2014

NIH: Midcareer Investigator Award in Patient-Oriented Research (Parent K24)

The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates or equivalent who are typically at the Associate Professor level or the equivalent (see Section III. Eligible Individuals) for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty.

Announcement #: PA-11-195
Posted:  April 8, 2011
Funding Level:  see announcement, up to five years
Letter of Intent Due:  NA
Due Date: February 12, June 12, October 12; exp Sept 8, 2014

NIH: Patient Safety Research During Neonatal Care (R01)

This FOA encourages a wide range of collaborative research projects related to patient safety in the context of both routine as well as intensive newborn care. The FOA welcomes proposals related to (but not limited to): the epidemiology of various domains of medical errors and consequent patient harm; assessing the factors at various levels that contribute to such errors; and intervention strategies at individual, systems, and institutional-levels to help reduce and eliminate medical errors in the context neonatal care. It is anticipated that knowledge gained from these projects will help develop strategies to deliver highest quality of healthcare to all newborn infants with utmost safety and effectiveness.

Announcement #: PAR-11-225
Posted:  June 9, 2011
Funding Level:  not specified, up to five years
Letter of Intent Due:  August 19, 2011, August 19, 2012, August 19, 2013
Due Date:   September 19, 2012, September 19, 2013

NIH: Patient Safety Research during Neonatal Care (R03)

This FOA encourages a wide range of collaborative research projects related to patient safety in the context of both routine as well as intensive newborn care. The FOA welcomes proposals related to (but not limited to): the epidemiology of various domains of medical errors and consequent patient harm; assessing the factors at various levels that contribute to such errors; and intervention strategies at individual, systems, and institutional-levels to help reduce and eliminate medical errors in the context neonatal care. It is anticipated that knowledge gained from these projects will help develop strategies to deliver highest quality of healthcare to all newborn infants with utmost safety and effectiveness.

Announcement #: PAR-11-226
Posted:  June 9, 2011
Funding Level:  not specified, up to five years
Letter of Intent Due:  August 19, 2011, August 19, 2012, August 19, 2013
Due Date:   September 19, 2012, September 19, 2013


Systems Science and Health in the Behavioral and Social Sciences (R21)

This Funding Opportunity Announcement (FOA) issued by the Office of Behavioral and Social Sciences Research (OBSSR), and the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging (NIA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute of Environmental Health Sciences (NIEHS), the National Institute of General Medical Sciences (NIGMS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) at the National Institutes of Health, encourages Research Project Grant (R21) applications from institutions/organizations that propose to develop basic and applied projects utilizing systems science methodologies relevant to human behavioral and social sciences and health. This FOA is intended to encourage a broader scope of topics to be addressed with systems science methodologies, beyond those encouraged by existing open FOAs. Research projects applicable to this FOA are those that are either applied or basic in nature (including methodological development), have a human behavioral and/or social science focus, and feature systems science methodologies.
Announcement #: PAR-11-315
Posted:  August 17, 2011
Funding Level: $275,000 total for up t 2 years
Letter of Intent Due:  30 days before deadline
Due Date:   Febraury 16, June 16, October 16; exp Sept 8, 2014


Systems Science and Health in the Behavioral and Social Sciences (R01)

This Funding Opportunity Announcement (FOA) issued by the Office of Behavioral and Social Sciences Research (OBSSR) and the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging (NIA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute of Environmental Health Sciences (NIEHS), the National Institute of General Medical Sciences (NIGMS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) at the National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations that propose to develop basic and applied projects utilizing systems science methodologies relevant to human behavioral and social sciences and health. This FOA is intended to encourage a broader scope of topics to be addressed with systems science methodologies, beyond those encouraged by existing open FOAs. Research projects applicable to this FOA are those that are either applied or basic in nature (including methodological development), have a human behavioral and/or social science focus, and feature systems science methodologies.
Announcement #: PAR-11-314
Posted:  August 17, 2011
Funding Level: Not specified
Letter of Intent Due:  30 days before deadline
Due Date:   February 5, June 5, October  5;
exp Sept 8, 2014

Drug Abuse Prevention Intervention Research (R03)

The purpose of this FOA is to encourage Small Research Grant (R03) applications from institutions/organizations that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (e.g., mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C).  
Announcement #: PA-11-313
Posted:  August 16, 2011
Funding Level: $50,000 per year up to 2 years
Letter of Intent Due:  NA
Due Date:    February 16, June 16, October  16; exp Sept 8, 2014

Drug Abuse Prevention Intervention Research (R01)

he purpose of this FOA is to encourage Research Project Grant (R01) applications from institutions/organizations that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C).   

Announcement #: PA-11-311
Posted:  August 16, 2011
Funding Level: Not specified  per year up to 5 years
Letter of Intent Due:  NA
Due Date:   February 5, June 5, October  5; exp Sept 8, 2014

Drug Abuse Prevention Intervention Research (R21)

The purpose of this FOA is to encourage Exploratory/Developmental (R21) applications from institutions/organizations that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C).   

Announcement #: PA-11-312
Posted:  August 16, 2011
Funding Level: $275,000 per year up to 2 years
Letter of Intent Due:  NA
Due Date: February 16, June 16, October  16; exp Sept 8, 2014

T1 Translational Research:  Novel interventions for prevention and treatment of age-related conditions (R21)

This funding opportunity announcement (FOA) encourages exploratory/developmental R21 research projects to accelerate the pace of development of novel therapeutics involving biologics, pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly.   For the purposes of this FOA, T1 translational research on aging is defined as the application of basic and clinical biomedical findings towards the development of new strategies for prevention and treatment of age-related pathologies. For projects proposing basic research that is being conducted in animal models, the potential to treat a clinical age-related pathology must be clearly stated in the proposal.  Direct relevance of the data to a clinical aging condition must be established and clearly stated in the application.
Announcement #: PAS-11-280
Posted:  July 25, 2011
Funding Level:  $275,000 over 2 years
Letter of Intent Due:  NA
Due Date:   February 16, June 16, October  16; exp Sept 8, 2014

T2 Translational Research:  Research leading to new health care practices, community programs and policies affecting older persons (R21)

This funding opportunity announcement (FOA)  encourages exploratory/developmental R21 research projects on translational research (T2) directed towards development of health care practices, community programs and policies, including monitoring and quality improvement for pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly.  For the purposes of this FOA, T2 translational research on aging is defined as research to gather information needed to develop or evaluate methods of translating results from clinical studies into everyday clinical practice and health decision making (e.g., adapting an efficacious intervention for application in clinical practice and evaluating its effectiveness in different clinical settings). Methods for T2 translational research include but are not limited to intervention studies, systematic reviews, meta analysis, outcomes research and implementation research.
Announcement #: PAS-11-281
Posted:  July 25, 2011
Funding Level: $275,000 over 2 years
Letter of Intent Due:  NA
Due Date: February 16, June 16, October  16; exp Sept 8, 2014


Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R21)

The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative research. This FOA encourages research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need.
The two overarching goals of this FOA are to encourage projects that will 1) improve the uptake of efficacious interventions and 2) conduct research to inform and enhance the effectiveness and efficiency of interventions, in order to maximize community impact.

Announcement #: PA-11-273
Posted:  July 26, 2011
Funding Level: $275,000 over 2 year period
Letter of Intent Due:  NA
Due Date: 
February 16, June 16, October  16; exp Sept 8, 2014

Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R34)

The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative research. This FOA encourages research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need.
The two overarching goals of this FOA are to encourage projects that will 1) improve the uptake of efficacious interventions and 2) conduct research to inform and enhance the effectiveness and efficiency of interventions, in order to maximize community impact.
Announcement #: PA-11-274
Posted:  July 26, 2011
Funding Level: $450,000 over 3 year period
Letter of Intent Due:  NA
Due Date:  February 16, June 16, October  16; exp Sept 8, 2014

Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R03)

The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative research. This FOA encourages research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need.
The two overarching goals of this FOA are to encourage projects that will 1) improve the uptake of efficacious interventions and 2) conduct research to inform and enhance the effectiveness and efficiency of interventions, in order to maximize community impact.

Announcement #: PA-11-272
Posted:  July 26, 2011
Funding Level: $50,000 per year up to 2 years
Letter of Intent Due:  NA
Due Date:   February 16, June 16, October  16; exp Sept 8, 2014

Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R21)

The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml, particularly objectives 1, 2, and 3 as adapted to HIV research.

Announcement #: PA-11-277
Posted:  July 26, 2011
Funding Level:
Letter of Intent Due:  NA
Due Date:  February 16, June 16, October  16; exp Sept 8, 2014

Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R34)

The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan  http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml, particularly objectives 1, 2, and 3 as adapted to HIV research.

Announcement #: PAR-11-278
Posted:  July 26, 2011
Funding Level: $450,000 over 3 years
Letter of Intent Due:  NA
Due Date:   February 16, June 16, October  16; exp Sept 8, 2014

Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R03)

The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan  http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml, particularly objectives 1, 2, and 3 as adapted to HIV research.

Announcement #: PAR-11-276
Posted:  July 26, 2011
Funding Level: $50,000 over 2 years
Letter of Intent Due:  NA
Due Date:  February 16, June 16, October  16; exp Sept 8, 2014

Behavioral and Social Genomics of Aging: Opportunities in the Health and Retirement Study (R01)

The Health and Retirement Study (HRS; see at http://hrsonline.isr.umich.edu/ ) is a longitudinal, nationally representative sample of the US population aged 50 years and older (plus spouses) with an oversample of African and Hispanic Americans and a total sample size of over 20,000). Using funds from the American Reinvestment and Recovery Act, the HRS is currently conducting genome-wide scans of DNA samples from approximately 20,000 participants, using the Illumina HumanOmni 2.5 Quad chip. It is anticipated that the genotype data for the first 13,000 subjects will be released to the public via dbGaP in the Fall of 2011, with data from the remaining participants to be released by the end of 2012. This FOA encourages applications taking advantage of the newly available genetic data to advance our understanding of how genetic, behavioral, and psychosocial factors affect the health and well-being of older Americans.

Announcement #: PA-11-318
Posted:  August 22, 2011
Funding Level: Not specified up to 5 years
Letter of Intent Due:  NA
Due Date:    February 5, June 5, October  5; exp Sept 8, 2014

 

AHRQ Health Services Research Projects (R01)

This Funding Opportunity Announcement (FOA) solicits Large Research (R01) Projects, and expresses AHRQ portfolio priority areas of interest for ongoing extramural health services research, demonstration, dissemination, and evaluation grants.
Announcement #: PA-09-070 
Posted:  October 6, 2011
Funding Level:  500,000 per year up to 5 years
Letter of Intent Due:  NA
Due Date:   October 5; exp Jan 8, 2013

Mentored  Clinical Scientist Research Career Development Award (K08)
The primary purpose of the AHRQ Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans.  This program represents the continuation of an AHRQ program that provides support and “protected time” to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in health services research.  The award can be used both by individuals who propose to newly embark in heath services research training and those who had a hiatus in their research careers because of illness or family circumstances.  The award is also available to promote research workforce diversity by providing enhanced research career development opportunities.  Candidates interested in pursuing careers in patient-oriented research are eligible to apply for this award at AHRQ.
Announcement #: PAR-09-085
Posted:  October 6, 2011
Funding Level:
Letter of Intent Due: 
Due Date:   November 12; exp Jan 8, 2013

Improving Adherence in Pre-teens, Adolescents and Young Adults with Type 1 Diabetes (DP3)

This FOA issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, encourages Research Project Grant (DP3) applications from institutions/organizations proposing to develop, refine, and pilot test innovative strategies to improve adherence to medications and medical regimens, including self-management, in pre-teens, adolescents, and young adults with type 1 diabetes. At the end of the funding period, there should be a well-developed and well-characterized intervention that has been demonstrated to be safe, feasible to implement, acceptable in the target population, and, if promising, ready to be tested in a larger efficacy trial.
Announcement #: RFA-DK-11-029
Posted:  November 1, 2011
Funding Level: $400,000 per year up to 4 years
Letter of Intent Due:  February 2, 2012
Due Date:  March 2, 2012

mHealth Tools to Promote Effective Patient–Provider Communication, Adherence to Treatment  and Self Management of Chronic Diseases In Underserved Populations (R03)

The purpose of this initiative issued by the National Institute of Nursing Research (NINR) and the Office of Dietary Supplements (ODS) is to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patient–provider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database.  mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies in underserved populations.

Announcement #: PA-11-331
Posted:  September 2, 2012
Funding Level: $50,000 per year for 2 years
Letter of Intent Due:   NA
Due Date:  February 16, June 16, October 16; exp Sept 8, 2014

mHealth Tools to Promote Effective Patient–Provider Communication, Adherence to Treatment  and Self Management of Chronic Diseases In Underserved Populations (R01)

The purpose of this initiative issued by the National Institute of Nursing Research (NINR) and the Office of Dietary Supplements (ODS) is to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patient–provider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database.  mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies in underserved populations.

Announcement #: PA-11-330
Posted:  September 2, 2012
Funding Level: Not specified for 5 years
Letter of Intent Due:   NA
Due Date:  February 5, June 5, October 5; exp Sept 8, 2014

Academic-Community Partnership Conference Series (R13)

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages Research Conference Grant (R13) applications to conduct health disparities-related meetings, workshops, and symposia. The purpose of the Academic-Community Partnership Conference Series is to bring together academic institutions/organizations and community organizations to identify opportunities for addressing health disparities through the use of Community-Based Participatory Research (CBPR). The objectives of meetings conducted as part of this award will be to: (1) establish and/or enhance academic-community partnerships; (2) identify community-driven research priorities, and (3) develop long-term collaborative CBPR research agendas. Thus, it is expected these partnerships will lead to grant applications for the support of CBPR projects designed to meet identified community needs. The areas of focus for these partnerships may include one or more of the following community-health issues: infant mortality; Sudden Infant Death Syndrome (SIDS); fibroid tumors; childhood, adolescent, and/or adult obesity; health literacy; techniques for outreach and information dissemination; pediatric and maternal HIV/AIDS prevention; and violence prevention.
Announcement #:PAR-12-102
Posted:  February 10, 2012
Funding Level: $30,000 per  year up to 3 years
Letter of Intent Due:  NA
Due Date:  April 10, 2012, Oct. 17, 2013,Oct 17, 2014

NSF:  Decision, Risk and Management Sciences

(DRMS)

The Decision, Risk and Management Sciences program supports scientific
research directed at increasing the understanding and effectiveness of
decision making by individuals, groups, organizations, and society.
Disciplinary and interdisciplinary research, doctoral dissertation
research, and workshops are funded in the areas of judgment and decision
making; decision analysis and decision aids; risk analysis, perception,
and communication; societal and public policy decision making;
management science and organizational design. The program also supports
small grants that are time-critical (Rapid Response Research - RAPID)and
small grants that are high-risk and of a potentially transformative
nature (EArly-Concept Grants for Exploratory Research - EAGER). 

Announcement #: 98-1321
Funding Level: varies
Due Dates: 

Full Proposal Target Date:  August 18, 2012

August 18, Annually Thereafter

August 18, Annually Thereafter

Full Proposal Target Date:  January 18, 2013

January 18, Annually Thereafter

January 18, Annually Thereafter